Try our mobile app

Published: 2022-09-08 00:00:00 ET
<<<  go to NDSN company page
HTTP/1.1 200 OK HTTP/1.1 200 OK X-Crawlera-Slave: 181.215.83.90:3128 X-Crawlera-Version: 1.60.1 accept-ranges: bytes content-type: text/html last-modified: Thu, 08 Sep 2022 20:32:11 GMT server: AmazonS3 x-amz-id-2: kSZDmd8kelVaIT7TCy5X6u+LobFeqjxbqVd9V2vCOHnQuJsE+/e/DYjkWZ3863IE6fI08YOGaBc= x-amz-meta-mode: 33188 x-amz-meta-s3cmd-attrs: uid:504/gname:fitrprnt/uname:fitrprnt/gid:504/mode:33184/mtime:1662669128/atime:1662669128/md5:d05626d2a651b668c2287d5a5c1b5cb9/ctime:1662669128 x-amz-replication-status: COMPLETED x-amz-request-id: 0E0TNPE1JPA04FVC x-amz-version-id: Hm3y98bkIc1lnTz9TWMqaX1.C1NAdhLc x-content-type-options: nosniff x-frame-options: SAMEORIGIN x-xss-protection: 1; mode=block x-akamai-transformed: 9 8585 0 pmb=mTOE,2 expires: Wed, 05 Apr 2023 21:51:04 GMT cache-control: max-age=0, no-cache, no-store pragma: no-cache date: Wed, 05 Apr 2023 21:51:04 GMT vary: Accept-Encoding akamai-x-true-ttl: -1 strict-transport-security: max-age=31536000 ; includeSubDomains ; preload set-cookie: ak_bmsc=29C0CD0768909C702C360F3CB8F0BF09~000000000000000000000000000000~YAAQDWIoF55jujKHAQAA0uFmUxNVQ93DI6gj3LsKYrnBh/nVsgpCvKiXhCSITgu5na5UKrjD38VlYqvymryzQ63zhXX2g0Gh6Y2t9SnFSlDw2iCU9co4ffKIUj8MXGU3lx38/sShKPnHe1OuE3PcM9JUO6BE73Z1hcif6ROwtJZDYsmQ9gTXRn2352vOdWdzUQWUn2sIQPGO3geb4VEHU6BIqsJx68Ljr9L2g5um1OwFekv5W31KX2IcvT5UiwIqXde5pm/5jojgXv7XPmdQpMhhvZmeSBsuttXyqzrevpVnnUW8JDhiA5m8sMAJiyMda6w9Scxfinnp7BogiYE7XXvg9Eqtn2M6iVIK2W0tIYNEp9XCR66nPPNarI3BCkbvcxJv3PXWvw==; Domain=.sec.gov; Path=/; Expires=Wed, 05 Apr 2023 23:51:03 GMT; Max-Age=7199; HttpOnly set-cookie: bm_mi=F42F3052E985ED50B72DA774C8F7055A~YAAQDWIoF59jujKHAQAA0uFmUxNt4RFHqSSTZyO1QhvN5Zb38qKasr2c6b6vl84y9h86mR+CBU0hZ3NwfbmWRcO/g4Dk4iiKfry2Qd5gvowxUv9jvH4+Um3KZA854SARM8hZpVgaULXL2rw1eLMInuPQVglwvGZL7yaOfH+6sK/8Y1V23rXbLxzcTNPOKqknMTVi5I2l1oqyqVlDTN+ZgeCJEe4vgSJU3dvwfdcL8zuDOnh5YW0at15DdETl3xua6SQwFv0SfL96TYnX1cU1xl1W5kKCbYsxjm6MaTW1inyJ6B8NuRkaJFxlJnjPJEpYXdwupuU8lxjSpEgF57obFLMhXI6BOJsw3mn7LpnB/xfVxf+MJOIzPtBEFk5TZAfh8bDCYscC4R1KwxBrn05lnQ==~1; Domain=.sec.gov; Path=/; Expires=Wed, 05 Apr 2023 21:51:04 GMT; Max-Age=0; Secure Transfer-Encoding: chunked Proxy-Connection: close Connection: close EX-99.1 2 ndsn-sep20228kxex991.htm EX-99.1 Document
Exhibit 99.1
RECONCILIATION OF NON-GAAP MEASURES - ADJUSTED OPERATING PROFIT AND EBITDA (Unaudited)
(Dollars in thousands)
Three Months EndedYTD
July 31, 2022April 30, 2022January 31, 2022July 31, 2022
SALES BY SEGMENT
Industrial precision solutions$341,215 $316,434 $323,933 $981,582 
Medical and fluid solutions177,840 172,212 158,784 508,836 
Advanced technology solutions143,073 146,757 126,449 416,279 
Total sales$662,128 $635,403 $609,166 $1,906,697 
OPERATING PROFIT
Industrial precision solutions$119,706 $102,196 $102,187 $324,089 
Medical and fluid solutions58,103 58,314 49,093 165,510 
Advanced technology solutions28,155 40,144 27,234 95,533 
Corporate(21,046)(16,681)(22,654)(60,381)
Total operating profit$184,918 $183,973 $155,860 $524,751 
OPERATING PROFIT ADJUSTMENTS (1)
Industrial precision solutions$— $— $1,563 $1,563 
Medical and fluid solutions2,498 — — 2,498 
Corporate897 — — 897 
Total adjustments$3,395 $— $1,563 $4,958 
ADJUSTED OPERATING PROFIT (NON-GAAP) (2)
Industrial precision solutions$119,706 $102,196 $103,750 $325,652 
Medical and fluid solutions60,601 58,314 49,093 168,008 
Advanced technology solutions28,155 40,144 27,234 95,533 
Corporate(20,149)(16,681)(22,654)(59,484)
Total operating profit - adjusted$188,313 $183,973 $157,423 $529,709 
DEPRECIATION & AMORTIZATION
Industrial precision solutions$6,347 $6,916 $7,442 $20,705 
Medical and fluid solutions15,021 13,578 13,547 42,146 
Advanced technology solutions2,195 2,247 2,263 6,705 
Corporate1,324 2,224 2,138 5,686 
Total depreciation & amortization$24,887 $24,965 $25,390 $75,242 
EBITDA (NON-GAAP) (2)
Industrial precision solutions$126,053 $109,112 $111,192 $346,357 
Medical and fluid solutions75,622 71,892 62,640 210,154 
Advanced technology solutions30,350 42,391 29,497 102,238 
Corporate(18,825)(14,457)(20,516)(53,798)
Total EBITDA$213,200 $208,938 $182,813 $604,951 
(1) Represents severance and other non-cash inventory charges associated with the NDC acquisition.
(2) Adjusted operating profit and EBITDA are non-GAAP measures used by management to evaluate the Company's ongoing operations. Adjusted operating profit is defined as operating profit plus certain adjustments, such as severance and non-cash inventory charges associated with acquisitions or facility closures. EBITDA is defined as adjusted operating profit plus depreciation and amortization.


RECONCILIATION OF NON-GAAP MEASURES - ADJUSTED OPERATING PROFIT AND EBITDA (Unaudited)
(Dollars in thousands)
Three Months EndedYTD
October 31, 2021July 31, 2021April 30, 2021January 31, 2021October 31, 2021
SALES BY SEGMENT
Industrial precision solutions$314,307 $345,449 $298,775 $288,416 $1,246,947 
Medical and fluid solutions163,504 169,119 168,771 140,260 641,654 
Advanced technology solutions121,436 132,290 121,992 97,890 473,608 
Total sales$599,247 $646,858 $589,538 $526,566 $2,362,209 
OPERATING PROFIT
Industrial precision solutions$102,677 $123,829 $104,283 $83,403 $414,192 
Medical and fluid solutions50,758 53,370 55,903 38,163 198,194 
Advanced technology solutions16,346 27,399 20,682 9,039 73,466 
Corporate(18,346)(16,322)(14,477)(21,580)(70,725)
Total operating profit$151,435 $188,276 $166,391 $109,025 $615,127 
DEPRECIATION & AMORTIZATION
Industrial precision solutions$6,259 $5,964 $6,468 $6,982 $25,673 
Medical and fluid solutions14,033 15,477 13,427 13,663 56,600 
Advanced technology solutions2,954 2,997 2,994 2,881 11,826 
Corporate2,404 2,460 2,427 2,493 9,784 
Total depreciation & amortization$25,650 $26,898 $25,316 $26,019 $103,883 
EBITDA (NON-GAAP) (1)
Industrial precision solutions$108,936 $129,793 $110,751 $90,385 $439,865 
Medical and fluid solutions64,791 68,847 69,330 51,826 254,794 
Advanced technology solutions19,300 30,396 23,676 11,920 85,292 
Corporate(15,942)(13,862)(12,050)(19,087)(60,941)
Total EBITDA$177,085 $215,174 $191,707 $135,044 $719,010 
(1) Adjusted operating profit and EBITDA are non-GAAP measures used by management to evaluate the Company's ongoing operations. Adjusted operating profit is defined as operating profit plus certain adjustments, such as cost structure simplification actions. EBITDA is defined as adjusted operating profit plus depreciation and amortization.


RECONCILIATION OF NON-GAAP MEASURES - ADJUSTED OPERATING PROFIT AND EBITDA (Unaudited)
(Dollars in thousands)
Three Months EndedYTD
October 31, 2020July 31, 2020April 30, 2020January 31, 2020October 31, 2020
SALES BY SEGMENT
Industrial precision solutions$308,385 $288,965 $282,274 $263,799 $1,143,423 
Medical and fluid solutions148,032 136,773 144,792 135,302 564,899 
Advanced technology solutions102,108 112,443 102,412 95,815 412,778 
Total sales$558,525 $538,181 $529,478 $494,916 $2,121,100 
OPERATING PROFIT
Industrial precision solutions$425 $74,744 $76,454 $56,405 $208,028 
Medical and fluid solutions43,414 32,049 43,049 31,784 150,296 
Advanced technology solutions7,260 17,903 15,640 503 41,306 
Corporate(13,731)(12,641)(10,114)(13,599)(50,085)
Total operating profit$37,368 $112,055 $125,029 $75,093 $349,545 
OPERATING PROFIT ADJUSTMENTS (1)
Industrial precision solutions$91,419 $2,813 $364 $300 $94,896 
Medical and fluid solutions44 3,147 — — 3,191 
Advanced technology solutions1,380 266 — 2,970 4,616 
Corporate— 1,387 — — 1,387 
Total adjustments$92,843 $7,613 $364 $3,270 $104,090 
ADJUSTED OPERATING PROFIT (NON-GAAP) (2)
Industrial precision solutions$91,844 $77,557 $76,818 $56,705 $302,924 
Medical and fluid solutions43,458 35,196 43,049 31,784 153,487 
Advanced technology solutions8,640 18,169 15,640 3,473 45,922 
Corporate(13,731)(11,254)(10,114)(13,599)(48,698)
Total operating profit - adjusted$130,211 $119,668 $125,393 $78,363 $453,635 
DEPRECIATION & AMORTIZATION
Industrial precision solutions$9,951 $9,865 $9,296 $9,827 $38,939 
Medical and fluid solutions13,832 13,535 12,606 13,615 53,588 
Advanced technology solutions2,878 2,731 2,639 2,707 10,955 
Corporate2,477 2,369 2,505 2,469 9,820 
Total depreciation & amortization$29,138 $28,500 $27,046 $28,618 $113,302 
EBITDA (NON-GAAP) (2)
Industrial precision solutions$101,795 $87,422 $86,114 $66,532 $341,863 
Medical and fluid solutions57,290 48,731 55,655 45,399 207,075 
Advanced technology solutions11,518 20,900 18,279 6,180 56,877 
Corporate(11,254)(8,885)(7,609)(11,130)(38,878)
Total EBITDA$159,349 $148,168 $152,439 $106,981 $566,937 
(1) Represents assets held for sale impairment charge, costs and adjustments related to cost structure simplification actions, and charges associated with our 2020 acquisition.
(2) Adjusted operating profit and EBITDA are non-GAAP measures used by management to evaluate the Company's ongoing operations. Adjusted operating profit is defined as operating profit plus certain adjustments, such as assets held for sale


impairment charge, severance and non-cash inventory charges associated with acquisitions or facility closures. EBITDA is defined as adjusted operating profit plus depreciation and amortization.
Management uses these non-GAAP measures internally to make strategic decisions, forecast future results, and evaluate the Company's current performance. Given management's use of these non-GAAP measures, the Company believes these measures are important to investors in understanding the Company's current and future operating results as seen through the eyes of management. In addition, management believes these non-GAAP measures are useful to investors in enabling them to better assess changes in the Company's core business across different time periods. Because non-GAAP financial measures are not standardized, it may not be possible to compare these financial measures to other companies' non-GAAP financial measures, even if they have similar names. Amounts may not add due to rounding.

Contact
Lara Mahoney
Vice President,
Investor Relations & Corporate Communications
440.204.9985
Lara.Mahoney@nordson.com